The partners overcame an earlier rejection to win a seventh use for Dupixent, though some analysts are skeptical of its sales ...

This could include allergy testing, blood tests to detect inflammation markers, or tests for celiac disease or thyroid problems. If the hives are not always apparent, it may help for a person to ...

The rash rarely itches and can blend into larger patches ... close contacts of immunocompromised individuals or those with ...

The FDA approved dupilumab for the treatment of patients 12 years and older with chronic spontaneous urticaria who remain ...

The FDA has approved Dupixent for the treatment of patients aged 12 years and older with CSU who remain symptomatic despite H1 antihistamine treatment.

Washington recorded its fifth case of the virus in 2025, as U.S. sees its biggest measles outbreak in years, with over 800 ...

Urticaria is complicated to diagnose by its symptomatic overlap with other skin conditions and the frequent misclassification ...

Chronic spontaneous urticaria is chronic inflammatory skin disease driven in part by type 2 inflammation, which causes sudden and debilitating hives and recurring itch.

Resubmission of the supplemental biologics license application provided more data on improvement in hives and itching in ...